Status:
COMPLETED
OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women
Lead Sponsor:
Universiti Tunku Abdul Rahman
Conditions:
Skin Diseases
Skin Disorder
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
OneDoc Picopulse™ is a radiopulse technology beauty grade device invented for treating melasma.
Detailed Description
This is a new attempt to evaluate the effectiveness of OneDoc PicopulseTM in treating melasma among women of childbearing age in Klang Valley, Malaysia. This pilot feasibility study protocol is to acc...
Eligibility Criteria
Inclusion
- Women presenting dermal melasma with Fritzpatrick skin type III to V
- Malaysian citizen
- Agreed to participate
- Provide informed consent
Exclusion
- Patients who had a laser procedure, phototherapy therapy, peel, oral therapy, topical treatment or used lightening creams in the treatment area within the past 6 months.
- Patients with pregnancy, lactating, active dermatitis, had a history of immunosuppression/immune deficiency disorders
- Patients who photosensitivity or taking drugs known to induce photosensitivity,
- Patients that have been exposed to severe sun exposure, having severe epidermal injury, allergy and sensitivity
- Patients who could not attend follow-up treatments
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04834167
Start Date
May 1 2021
End Date
December 1 2022
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OneDoc
Cheras, Malaysia